Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details)

v3.21.2
SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Accounts payable:    
Clinical and regulatory expenses $ 419 $ 232
Professional fees 636 1,183
Selling expenses 654 1,303
Manufacturing costs 112 4,541
Other vendors 352 18
Total accounts payable 2,173 7,277
Accrued interest payable, related parties 47 42
Accrued interest payable 523 991
Accrued expenses:    
Payroll expenses 1,024 891
Government rebates and other rebates 2,465 1,355
Due to EJ Holdings 474 238
Other accrued expenses 969 704
Total accrued expenses 4,932 3,188
Total accounts payable and accrued expenses $ 7,675 $ 11,498